Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life.
about
Clinical outcomes of HIV-exposed, HIV-uninfected children in sub-Saharan AfricaIncreased Risk of Group B Streptococcus Invasive Infection in HIV-Exposed but Uninfected Infants: A Review of the Evidence and Possible MechanismsThe Immune System of HIV-Exposed Uninfected InfantsLinking Susceptibility to Infectious Diseases to Immune System Abnormalities among HIV-Exposed Uninfected InfantsImpact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency.Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa.The role of environmental factors in modulating immune responses in early lifeImpaired haemophilus influenzae type b transplacental antibody transmission and declining antibody avidity through the first year of life represent potential vulnerabilities for HIV-exposed but -uninfected infants.Management of diarrhea in HIV-affected infants and children.HIV-Exposed Uninfected Infants Show Robust Memory B-Cell Responses in Spite of a Delayed Accumulation of Memory B Cells: an Observational Study in the First 2 Years of Life.Incidence of Severe and Nonsevere Pertussis Among HIV-Exposed and -Unexposed Zambian Infants Through 14 Weeks of Age: Results From the Southern Africa Mother Infant Pertussis Study (SAMIPS), a Longitudinal Birth Cohort Study.Bordetella pertussis Infection in South African HIV-Infected and HIV-Uninfected Mother-Infant Dyads: A Longitudinal Cohort StudyHIV-exposed uninfected children: a growing population with a vulnerable immune system?Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants.Antibodies against pneumococcal capsular polysaccharide in Malawian HIV-positive mothers and their HIV-exposed uninfected children.Immunogenicity of Hepatitis B Vaccine in HIV Exposed Uninfected Infants.Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013.Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants.B and T Cell Phenotypic Profiles of African HIV-Infected and HIV-Exposed Uninfected Infants: Associations with Antibody Responses to the Pentavalent Rotavirus Vaccine.The Effect of Human Immunodeficiency Virus and Cytomegalovirus Infection on Infant Responses to Vaccines: A Review.Feeding practices and nutritional status of HIV-exposed and HIV-unexposed infants in the Western Cape.Morbidity and mortality in HIV-exposed uninfected children
P2860
Q26749153-3C284A96-8F1F-4EF8-A3DC-B58BE9E66FF4Q28067423-ABDD7EBB-7298-4D84-B180-B1BFD5CEB0FCQ28069872-9F6690CB-E006-4689-9B8A-2B58E2B9847AQ28077904-1F7AC848-7AE6-4BA3-A8C1-FD56444EEBF5Q33624111-4B7DB099-A9A4-4430-B512-6F86F06EC8D5Q33655929-E18716B9-3B6E-4BBC-9136-BB3BAEA87611Q34169396-C508121A-0814-4644-A7B7-0BB51FD2851AQ34593078-7EF85251-4F46-46AB-9BA8-86596B58B646Q36173342-3ED76FD6-B27A-4E74-B473-86DCABF520C1Q37067271-31D0B298-F5C0-4E8F-9B9D-0F4EFE97C6A8Q37410302-B5208BE6-C882-4C76-B5FA-F8ABDD3E58ACQ37410304-2DF2783E-55F6-4D1F-B74E-EEAD5A2B4F3CQ38170189-54A1767D-3C39-40AA-A37D-3A4158A6A2C1Q39017322-1CB10FF4-5B47-4EF5-A13B-8A6AB15684CEQ40894200-5CC6BD94-E703-420D-AA96-6FDB294E1EC2Q40959540-15FCD340-3347-47B0-BDC6-ECD8014215CEQ41489687-DC8271A0-BC75-4754-B5B8-EAE4CD8FC34FQ47131363-F4032575-47A8-4975-86AC-040F3D63CC9FQ48505891-B43B2046-385A-4BEE-9E28-172B83C42229Q52649837-1DE42EF1-19F3-4C2C-8CD9-EA23B0F96CAFQ53763322-0094F096-62AE-4DA1-A12B-10A3B6308777Q55546839-E3AC5176-88D9-4210-A090-956E2540650A
P2860
Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Antibody responses to vaccinat ...... ing the first 2 years of life.
@ast
Antibody responses to vaccinat ...... ing the first 2 years of life.
@en
type
label
Antibody responses to vaccinat ...... ing the first 2 years of life.
@ast
Antibody responses to vaccinat ...... ing the first 2 years of life.
@en
prefLabel
Antibody responses to vaccinat ...... ing the first 2 years of life.
@ast
Antibody responses to vaccinat ...... ing the first 2 years of life.
@en
P2093
P2860
P50
P356
P1476
Antibody responses to vaccinat ...... ring the first 2 years of life
@en
P2093
Amy L Slogrove
Brian A Reikie
Candice E Ruck
Corena de Beer
David P Speert
Heleen la Grange
Mark F Cotton
Monika Esser
Rozanne C M Adams
P2860
P356
10.1128/CVI.00557-12
P577
2012-10-31T00:00:00Z